The problem of post-breast cancer lymphedema: impact and measurement issues.
about
Side-to-end Lymphaticovenular anastomosis through temporary lymphatic expansionLymphatic vessel density and function in experimental bladder cancer.Near-Infrared Fluorescence Imaging in Humans with Indocyanine Green: A Review and Update30-MONTH POST-BREAST CANCER TREATMENT LYMPHOEDEMA.Quantitative and morphologic change associated with breast cancer-related lymphedema. Comparison of 3.0T MRI to external measuresThe aesthetic rationality of the popular expressive arts: Lifeworld communication among breast cancer survivors living with lymphedemaPrescription and adherence to lymphedema self-care modalities among women with breast cancer-related lymphedemaBreast cancer treatment, BMI, post-op swelling/lymphoedema.Spatio-temporal changes of lymphatic contractility and drainage patterns following lymphadenectomy in mice.Pre-operative assessment enables early diagnosis and recovery of shoulder function in patients with breast cancerProblem-solving style and adaptation in breast cancer survivors: a prospective analysis.Standardized method for quantification of developing lymphedema in patients treated for breast cancer.Side of cancer does not influence limb volumes in women prior to breast cancer surgeryRisk factors for lymphedema after breast cancer treatment.Risk factors for lymphedema in a prospective breast cancer survivorship study: the Pathways Study.Human Lymphatic Architecture and Dynamic Transport Imaged Using Near-infrared Fluorescence.Direct evidence of lymphatic function improvement after advanced pneumatic compression device treatment of lymphedema.The Alberta moving beyond breast cancer (AMBER) cohort study: a prospective study of physical activity and health-related fitness in breast cancer survivors.Life after breast cancer: dealing with lymphoedemaSurveillance recommendations in reducing risk of and optimally managing breast cancer-related lymphedemaAssociation between lymphedema self-care adherence and lymphedema outcomes among women with breast cancer-related lymphedema.Effect of manual lymph drainage in addition to guidelines and exercise therapy on arm lymphoedema related to breast cancer: randomised controlled trialPost-breast cancer lymphedema: incidence increases from 12 to 30 to 60 months.Best Practice Guidelines in Assessment, Risk Reduction, Management, and Surveillance for Post-Breast Cancer Lymphedema.Using temporal mining to examine the development of lymphedema in breast cancer survivorsA threshold model of social support, adjustment, and distress after breast cancer treatmentProspective Lymphedema Surveillance in a Clinic SettingA randomized controlled trial comparing two types of pneumatic compression for breast cancer-related lymphedema treatment in the home.Measurement Issues in Anthropometric Measures of Limb Volume Change in Persons at Risk for and Living with Lymphedema: A Reliability Study.Validity of Quantitative Lymphoscintigraphy as a Lymphedema Assessment Tool for Patients With Breast Cancer.An aerobic weight-loaded pilot exercise intervention for breast cancer survivors: bone remodeling and body composition outcomes.Comparison of relative versus absolute arm size change as criteria for quantifying breast cancer-related lymphedema: the flaws in current studies and need for universal methodology.A pilot study using the Gynecologic Cancer Lymphedema Questionnaire (GCLQ) as a clinical care tool to identify lower extremity lymphedema in gynecologic cancer survivorsThe effect of prospective monitoring and early physiotherapy intervention on arm morbidity following surgery for breast cancer: a pilot studyComparison of diagnostic accuracy of clinical measures of breast cancer-related lymphedema: area under the curveLymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms.Bioelectrical impedance for detecting upper limb lymphedema in nonlaboratory settings.Defining a threshold for intervention in breast cancer-related lymphedema: what level of arm volume increase predicts progression?A novel intralymphatic nanocarrier delivery system for cisplatin therapy in breast cancer with improved tumor efficacy and lower systemic toxicity in vivo.Risk Factors Associated with Lymphedema among Postmenopausal Breast Cancer Survivors after Radical Mastectomy and Axillary Dissection in China
P2860
Q27333649-0709C9A0-0AC6-48A1-9BA8-DC07EBCAC7B3Q30481281-4E84A1CE-7470-4BF9-B419-1379C1DC7123Q30524322-2674C610-229F-493A-8BBB-78E05440F21AQ33680816-78A98129-66EE-4DB2-9A21-A84336C182BDQ33772743-B298466F-FD95-4007-B6FC-6071606B1FC1Q33990836-78435909-A059-4613-8BED-8F0A9D8C9185Q34004921-115135AE-6079-45A8-BA55-E396DEF82701Q34012939-73FC35C0-60AA-4580-86E3-40F95EBE4B63Q34110297-98E5DC10-9924-4B51-B9E2-65DCD00BB853Q34133156-591D2C25-BCEA-4981-B8DB-50358A4C3CF2Q34168394-9E7C364D-52F7-414B-9B6C-4DB4926D38F2Q34186773-3DEE5C3A-5219-462F-A36F-45BE02BC8BEEQ34224473-2EE45408-727E-4ED4-82AC-13C1F69945C9Q34293178-15839EBD-B55A-4D15-9B11-129E4FF6468CQ34383994-26DAD42F-EB1A-47AF-9CBA-580E23D1BDFAQ34398305-2C5A71A6-6191-4724-8DD7-0D6A0B0D8485Q34420507-76C7A421-008F-45BD-A6DD-34CFC20A28D9Q34478536-DA07E339-6387-4775-8517-EF2CB78C9049Q34578623-A731FD72-A88F-4FA0-B70F-9E032E639DE4Q34683882-63E46F8B-0A62-45BF-85F9-A841F4834EF1Q35132569-FC2E70A3-9742-425B-AF13-567BBC81B7A0Q35187741-50E0096A-5462-456D-B266-BFA3BCA18B09Q35903997-65D2F5AE-0A3E-4311-9C18-3952164DD758Q35911603-5DBF873D-958D-4381-B719-A6D292EA65BEQ35920386-48355073-E828-4AF2-A76B-629427D0D893Q35966926-2047ADC2-BB27-4CD5-B6A0-8307259D5C00Q36143736-F32A92DB-5418-4AC0-810E-99979DFFFC29Q36345481-39B91623-962C-49A6-A4F4-BBFC36AE754CQ36416066-FF614252-18A7-4A26-94F0-C7D543C89954Q36484754-0CD6E2D3-A4E5-4ACB-A183-E3023F8FA941Q36520117-375EBDFB-2CAF-4C18-8316-F64B440B609CQ36587170-0C8B420C-B581-4EF1-BEB4-FA540522D343Q36843577-733B44C2-F84A-4E5A-AB12-5005DB96AAADQ36905679-3F84E712-FFF6-4C2D-9C8D-B3EE0F8E01F8Q36972849-A82BD685-49FC-4BDF-858D-A7951DC70415Q37104754-6059EC98-04A1-464B-A7DD-2FAFAF09CA07Q37183703-D1F03F8D-E1EF-47BB-960E-9747FFD36212Q37210955-8B065F69-0E82-457A-862F-2A19379AD858Q37470083-CA69E17C-1F75-40E8-8290-2F528577D6E6Q37677687-C0F153B1-B622-4FB0-96EC-961B63439C0E
P2860
The problem of post-breast cancer lymphedema: impact and measurement issues.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
The problem of post-breast cancer lymphedema: impact and measurement issues.
@en
The problem of post-breast cancer lymphedema: impact and measurement issues.
@nl
type
label
The problem of post-breast cancer lymphedema: impact and measurement issues.
@en
The problem of post-breast cancer lymphedema: impact and measurement issues.
@nl
prefLabel
The problem of post-breast cancer lymphedema: impact and measurement issues.
@en
The problem of post-breast cancer lymphedema: impact and measurement issues.
@nl
P356
P1433
P1476
The problem of post-breast cancer lymphedema: impact and measurement issues.
@en
P2093
Jane M Armer
P356
10.1081/CNV-200048707
P577
2005-01-01T00:00:00Z